Zumutor Biologics, Inc.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Holding
- Established
- 2015-01-01
- Employees
- 11
- Market Cap
- -
- Website
- http://www.zumutor.com
Clinical Trials
1
Active:0
Completed:0
Trial Phases
1 Phases
Phase 1:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 1
1 (100.0%)Phase 1 Trial of ZM008 as Single Agent and in Combination With Pembrolizumab in Patients With Advanced Solid Tumors
Phase 1
Recruiting
- Conditions
- Non Small Cell Lung CancerEsophageal CancerProstate CancerUrothelial CarcinomaTriple Negative Breast CancerPancreas AdenocarcinomaBiliary Tract CancerHigh Grade Ovarian Serous AdenocarcinomaDiffuse Large B Cell LymphomaHead and Neck Squamous Cell Carcinoma
- Interventions
- First Posted Date
- 2024-06-11
- Last Posted Date
- 2024-12-04
- Lead Sponsor
- Zumutor Biologics Inc.
- Target Recruit Count
- 33
- Registration Number
- NCT06451497
- Locations
- 🇺🇸
Dana Farber Cancer Institute, Boston, Massachusetts, United States
🇺🇸NEXT Oncology, San Antonio, Texas, United States
News
No news found